The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Open accessAbstract
We investigated the mechanisms by which inhibitors of prostaglandin G/H synthase-2 (PGHS-2; known colloquially as COX-2) increase the incidence of myocardial infarction and stroke. These inhibitors are believed to exert both their beneficial and their adverse effects by suppression of PGHS-2-derived prostacyclin (PGI(2)) and PGE(2). Therefore, the challenge remains to identify a mechanism whereby PGI(2) and PGE(2) expression can be suppressed while avoiding adverse cardiovascular events. Here, selective inhibition, knockout, or mutation of PGHS-2, or deletion of the receptor for PGHS-2-derived PGI(2), was shown to accelerate thrombogenesis and elevate blood pressure in mice. These responses were attenuated by COX-1 knock down, which mimics the beneficial effects of low-dose aspirin. PGE(2) biosynthesis is catalyzed by the coordinate actions of COX enzymes and microsomal PGE synthase-1 (mPGES-1). We show that deletion of mPGES-1 depressed PGE(2) expression, augmented PGI(2) expression, and had no effect on thromboxane biosynthesis in vivo. Most importantly, mPGES-1 deletion affected neither thrombogenesis nor blood pressure. These results suggest that inhibitors of mPGES-1 may retain their antiinflammatory efficacy by depressing PGE(2), while avoiding the adverse cardiovascular consequences associated with PGHS-2-mediated PGI(2) suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination
Meyers, E. N., Lewandoski, M., & Martin, G. R. (1998) · Nature Genetics · doi:10.1038/ng0298-136 · Cited by 1,031
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Coxibs and Cardiovascular Disease
FitzGerald, G. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048288 · Cited by 899
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Self-citationAltered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase
Trebino, C. E., Stock, J. L., Gibbons, C. P., Naiman, B. M., Wachtmann, T. S., Umland, J. P., Pandher, K., Lapointe, J.-M., Saha, S., Roach, M. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332766100 · Cited by 552
Arachidonic Acid Oxygenation by COX-1 and COX-2
Marnett, L. J., Rowlinson, S. W., Goodwin, D. C., Kalgutkar, A. S., & Lanzo, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22903 · Cited by 523
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
FitzGerald, G. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1225 · Cited by 518
Farkouh, M. E., Kirshner, H., Harrington, R. A., Ruland, S., Verheugt, F. W., Schnitzer, T. J., Burmester, G. R., Mysler, E., Hochberg, M. C., Doherty, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16894-3 · Cited by 490
Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
Kennedy, C. R. J., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C. D., Magnuson, M. A., Oates, J. A., Breyer, M. D., & Breyer, R. M. (1999) · Nature Medicine · doi:10.1038/5583 · Cited by 391
Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.ioi50013 · Cited by 329
Riendeau, D., Percival, M. D., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Falgueyret, J. ‐., Ford‐Hutchinson, A. W., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701076 · Cited by 322
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Tilley, S. L., Audoly, L. P., Hicks, E. H., Kim, H.-S., Flannery, P. J., Coffman, T. M., & Koller, B. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6579 · Cited by 249
Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis
Shimokawa, T., Kulmacz, R. J., DeWitt, D. L., & Smith, W. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30468-4 · Cited by 229
Effect of Leptin on Arterial Thrombosis Following Vascular Injury in Mice
Bodary, P. F. (2002) · JAMA · doi:10.1001/jama.287.13.1706 · Cited by 224
Egan, K. M., Wang, M., Lucitt, M. B., Zukas, A. M., Puré, E., Lawson, J. A., & FitzGerald, G. A. (2005) · Circulation · doi:10.1161/01.cir.0000153386.95356.78 · Cited by 193
Sigthorsson, G., Simpson, R. J., Walley, M., Anthony, A., Foster, R., Hotz–Behoftsitz, C., Palizban, A., Pombo, J., Watts, J., Morham, S. G., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33647 · Cited by 191
Cyclooxygenases, the Kidney, and Hypertension
Cheng, H.-F., & Harris, R. C. (2004) · Hypertension · doi:10.1161/01.hyp.0000116221.27079.ea · Cited by 179
Fabre, J.-E., Nguyen, M., Athirakul, K., Coggins, K., McNeish, J. D., Austin, S., Parise, L. K., FitzGerald, G. A., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10881 · Cited by 172
Crofford, L. J., Oates, J. C., McCune, W. J., Gupta, S., Kaplan, M. J., Catella-Lawson, F., Morrow, J. D., McDonagh, K. T., & Schmaier, A. H. (2000) · Arthritis & Rheumatism · Cited by 152
Prostacyclin protects against elevated blood pressure and cardiac fibrosis
Francois, H., Athirakul, K., Howell, D. N., Dash, R., Mao, L., Kim, H., Rockman, H. A., FitzGerald, G. A., Koller, B. H., & Coffman, T. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.005 · Cited by 151
Selective Cyclooxygenase-2 Inhibition by Nimesulide in Man
Cullen, L., Kelly, L. P., Connor, S. O., & Fitzgerald, D. J. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37830-9 · Cited by 144
Parecoxib, Valdecoxib, and Cardiovascular Risk
Furberg, C. D., Psaty, B. M., & FitzGerald, G. A. (2005) · Circulation · doi:10.1161/01.cir.0000155081.76164.17 · Cited by 128
Anti-inflammatory agents and renal function☆, ☆☆
Brater, D. C. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.37216 · Cited by 118
Carlson, S. H., & Wyss, J. M. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.e1 · Cited by 117
COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
Patrignani, P., Sciulli, M. G., Manarini, S., Santini, G., Cerletti, C., & Evangelista, V. (1999) · PubMed · Cited by 115
Reese, J., Zhao, X., Ma, W., Brown, N., Maziasz, T. J., & Dey, S. K. (2001) · Endocrinology · doi:10.1210/en.142.7.3198 · Cited by 103
Hui, Y., Cheng, Y., Smalera, I., Jian, W., Goldhahn, L., FitzGerald, G. A., & Funk, C. D. (2004) · Circulation · doi:10.1161/01.cir.0000147775.50954.aa · Cited by 99
Self-citationSeyberth, H. W., Sweetman, B. J., Frölich, J. C., et al. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90160-x · Cited by 94
Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages
Trebino, C. E., Eskra, J. D., Wachtmann, T. S., Perez, J. R., Carty, T. J., & Audoly, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412075200 · Cited by 93
Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney
Schneider, A., Zhang, Y., Zhang, M., Lu, W. J., Rao, R., Fan, X., Redha, R., Davis, L. S., BREYER, R. M., Harris, R. C., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00493.x · Cited by 84
Sexual Dimorphism in Renal Production of Prostanoids in Spontaneously Hypertensive Rats
Sullivan, J. C., Sasser, J. M., Pollock, D. M., & Pollock, J. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000156879.83448.93 · Cited by 78
Genetic model of selective COX2 inhibition reveals novel heterodimer signaling
Yu, Y., Fan, J., Chen, X., Wang, D., Klein–Szanto, A. J., Campbell, R. L., FitzGerald, G. A., & Funk, C. D. (2006) · Nature Medicine · doi:10.1038/nm1412 · Cited by 78
Praticò, D., Cyrus, T., Li, H., & FitzGerald, G. A. (2000) · Blood · doi:10.1182/blood.v96.12.3823 · Cited by 74
Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition
Yu, Y., Cheng, Y., Fan, J., Chen, X., Klein–Szanto, A. J., FitzGerald, G. A., & Funk, C. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23683 · Cited by 71
Self-citationLoftin, C. D., Trivedi, D. B., & Langenbach, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14924 · Cited by 71
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin
Momi, S., Emerson, M., Paul, W., Leone, M., Mezzasoma, A. M., Soldato, P. D., Page, C. P., & Gresele, P. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00223-5 · Cited by 65
Rocca, B., Loeb, A. L., Strauss, J. F., Vezza, R., Habib, A., Li, H., & FitzGerald, G. A. (2000) · Nature Medicine · doi:10.1038/72334 · Cited by 59
Prostaglandin E Synthases in Zebrafish
Pini, B., Großer, T., Lawson, J. A., Price, T. S., Pack, M. A., & FitzGerald, G. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152355.97808.10 · Cited by 42
Takano, T., Cybulsky, A. V., Cupples, W. A., Ajikobi, D. O., Papillon, J., & Aoudjit, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043604 · Cited by 33
The choreography of cyclooxygenases in the kidney
FitzGerald, G. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216044 · Cited by 30
Effects of Salt Loading on Blood Pressure in Mice Lacking the Prostanoid Receptor Gene
Watanabe, H., Katoh, T., Eiro, M., Iwamoto, M., Ushikubi, F., Narumiya, S., & Watanabe, T. (2004) · Circulation Journal · doi:10.1253/circj.69.124 · Cited by 29
Tunçtan, B., Özveren, E., Korkmaz, B., et al. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.10.009 · Cited by 26
Shin, J., Hwang, K.-S., Kim, Y.-K., Leem, J., & Lee, C. J. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000184828.39754.a3 · Cited by 21
Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
Aw, T., Haas, S. J., Liew, D., & Krum, H. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.05.026 · Cited by 18
Pulmonary Embolism in a Woman Taking Oral Contraceptives and Valdecoxib
Westgate, E. J., & FitzGerald, G. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020197 · Cited by 6
Loftin, C. D., Trivedi, D. B., & Langenbach, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214924 · Cited by 6
The choreography of cyclooxygenases in the kidney
FitzGerald, G. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216044 · Cited by 2
Cited by
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?
Wallace, J. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00004.2008 · Cited by 716
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target
Samuelsson, B., Morgenstern, R., & Jakobsson, P.-J. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.1 · Cited by 538
Metadata
- Authors
- Cheng, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-05-01
- Volume
- 116
- Issue
- 5
- Pages
- 1391-1399
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2006306072
- Cited by
- 339
- References
- 53
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.